Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Total 13F shares
-
13,789,099
-
Share change
-
+188,879
-
Total reported value
-
$317,567,580
-
Put/Call ratio
-
1006%
-
Price per share
-
$23.03
-
Number of holders
-
92
-
Value change
-
+$4,354,645
-
Number of buys
-
54
-
Number of sells
-
23
Institutional Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q2 2014
As of 30 Jun 2014,
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,789,099 shares.
The largest 10 holders included
HEARTLAND ADVISORS INC, CARDINAL CAPITAL MANAGEMENT LLC /CT, ACK Asset Management LLC, CHARTWELL INVESTMENT PARTNERS, INC., WHITEBOX ADVISORS LLC, Lyon Street Capital, LLC, BLAIR WILLIAM & CO/IL, Cortina Asset Management, LLC, Park West Asset Management LLC, and THOMSON HORSTMANN & BRYANT INC.
This page lists
92
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.